January 25, 2018 / 8:29 AM / a month ago

BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine

Jan 25 (Reuters) - Baolingbao Biology Co Ltd:

* SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million) Source text in Chinese: bit.ly/2Dze5gs Further company coverage: ($1 = 7.8170 Hong Kong dollars) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below